PA
TGTX icon

Parallel Advisors’s TG Therapeutics TGTX Stock Holding History

Parallel Advisors’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.2K Buy
222
+67
+43% +$2.74K ﹤0.01% 2846
2026
Q1 		$5.15K Buy
155
+56
+57% +$1.67K ﹤0.01% 3020
2025
Q4 		$2.95K Hold
99
– – ﹤0.01% 3020
2025
Q3 		$3.58K Buy
99
+30
+43% +$988 ﹤0.01% 2906
2025
Q2 		$2.48K Sell
69
-48
-41% -$1.79K ﹤0.01% 2988
2025
Q1 		$4.61K Buy
117
+27
+30% +$908 ﹤0.01% 2710
2024
Q4 		$2.71K Sell
90
-9
-9% -$258 ﹤0.01% 2864
2024
Q3 		$2.32K Buy
99
+55
+125% +$1.2K ﹤0.01% 2853
2024
Q2 		$783 Buy
+44
New +$702 ﹤0.01% 3017
2024
Q1 		– Sell
-435
Closed -$7.43K – 3417
2023
Q4 		$7.43K Hold
435
– – ﹤0.01% 2396
2023
Q3 		$3.64K Hold
435
– – ﹤0.01% 2613
2023
Q2 		$10.8K Hold
435
– – ﹤0.01% 2140
2023
Q1 		$6.54K Hold
435
– – ﹤0.01% 2313
2022
Q4 		$5.15K Hold
435
– – ﹤0.01% 2319
2022
Q3 		$3K Hold
435
– – ﹤0.01% 2535
2022
Q2 		$2K Buy
+435
New +$2.72K ﹤0.01% 2645
2022
Q1 		– Sell
-528
Closed -$10K – 3272
2021
Q4 		$10K Buy
528
+478
+956% +$12.4K ﹤0.01% 2129
2021
Q3 		$2K Hold
50
– – ﹤0.01% 2739
2021
Q2 		$2K Sell
50
-14
-22% -$550 ﹤0.01% 2616
2021
Q1 		$3K Hold
64
– – ﹤0.01% 2408
2020
Q4 		$3K Buy
64
+19
+42% +$642 ﹤0.01% 2225
2020
Q3 		$1K Hold
45
– – ﹤0.01% 2496
2020
Q2 		$0 Buy
+45
New +$725 ﹤0.01% 2704

Other funds holding TGTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Parallel Advisors's TGTX Position: Q2 2026 in Review

Parallel Advisors increased its TG Therapeutics (TGTX) stake by 43% in Q2 2026, buying an estimated $2.74K and bringing the position to 222 shares worth $12.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2846.

Parallel Advisors first reported a position in TGTX in Q2 2020 and has held it in 23 quarters since. 429 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.

  • Parallel Advisors held 222 shares of TG Therapeutics worth $12.2K as of Q2 2026.
  • Parallel Advisors bought 67 TG Therapeutics shares in Q2 2026, an estimated $2.74K.
  • TG Therapeutics made up ﹤0.01% of Parallel Advisors's portfolio in Q2 2026, its #2846 holding.
  • Parallel Advisors first reported a position in TG Therapeutics in Q2 2020 and has held it in 23 quarters since.
  • 429 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.

Based on Parallel Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.